Studying Tumour Growth in Head and Neck Cancer
Author Information
Author(s): M.H. Bennett, G.D. Wilson, S. Dische, M.I. Saunders, C.A. Martindale, B.M. Robinson, A.E. O'Halloran, M.D. Leslie, J.H.E. Laing
Primary Institution: Mount Vernon Hospital, Northwood, UK
Hypothesis
Can combining flow cytometry and histology improve the assessment of tumour proliferation in squamous cell carcinoma of the head and neck?
Conclusion
The study found that combining flow cytometry and histology provides a more accurate assessment of tumour proliferation than either method alone.
Supporting Evidence
- Flow cytometry underestimated the labelling index in diploid tumours compared to histological evaluation.
- Combining flow cytometry data with histological labelling index increased the proportion of tumours identified as rapidly proliferating.
- 84% of tumours showed a potential doubling time of less than 5 days when both methods were used.
Takeaway
Doctors used two methods to look at how fast cancer cells grow in the head and neck, and found that using both methods together gives a better picture than just one.
Methodology
The study combined flow cytometry and immunohistochemical analysis of BrdUrd incorporation to assess tumour proliferation in patients with squamous cell carcinoma.
Potential Biases
Potential bias in sample selection and the subjective nature of histological assessment.
Limitations
The study may not account for all variations in tumour biology and the sample size, while significant, may not represent all head and neck cancers.
Participant Demographics
Patients with squamous cell carcinoma of the head and neck, with a total of 502 patients studied, 162 of whom had squamous cell cancers.
Statistical Information
P-Value
p<0.0001
Statistical Significance
p<0.0001
Want to read the original?
Access the complete publication on the publisher's website